MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/01.inf.0000245105.99934.5f

Медицинская библиотека · The Pediatric infectious disease journal · 2006

Ciprofloxacin treatment in preterm neonates in Bangladesh: lack of effects on growth and development.

Ahmed A S M Nawshad Uddin, Khan Naila Z, Saha Samir K, Chowdhury M A K Azad, Muslima Humaira, Law Paul, Islam Maksuda, Bhattacharya Mallika, Darmstadt Gary L

Клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Quinolone-induced arthropathic toxicity in weight-bearing joints observed in juvenile animals during preclinical testing has largely restricted the routine use of ciprofloxacin in the pediatric age group. As histopathologic, radiologic and magnetic resonance imaging monitoring evidence has gathered supporting the safety of fluoroquinolones in children, many pediatricians have started to prescribe quinolones to some patients on a compassionate basis.

OBJECTIVE

The objective of this study was to ascertain the safety of ciprofloxacin in preterm neonates <33 weeks gestational age treated at Dhaka Shishu (Children) Hospital in Bangladesh.

METHODS

Long-term follow up was done to monitor the growth and development of preterm infants who were administered intravenous ciprofloxacin in the neonatal period. Ciprofloxacin was used only as a life-saving therapy in cases of sepsis produced by bacterial agents resistant to other antibiotics. Another group of preterm neonates with septicemia who were not exposed to ciprofloxacin, but effectively treated with other antibiotics and followed up, were matched with cases for gender, gestational age and birth weight and included as a comparison group. Forty-eight patients in the ciprofloxacin group and 66 patients in the comparison group were followed up for a mean of 24.7 +/- 18.5 months and 21.6 +/- 18.8 months, respectively.

RESULTS

No osteoarticular problems or joint deformities were observed in the ciprofloxacin group during treatment or follow up. No differences in growth and development between the groups were found.

CONCLUSIONS

Ciprofloxacin is a safe therapeutic option for newborns with sepsis produced by multiply resistant organisms.

Для цитирования: Ahmed A S M Nawshad Uddin, Khan Naila Z, Saha Samir K, Chowdhury M A K Azad, Muslima Humaira, Law Paul, Islam Maksuda, Bhattacharya Mallika, Darmstadt Gary L. Ciprofloxacin treatment in preterm neonates in Bangladesh: lack of effects on growth and development.. The Pediatric infectious disease journal. 2006. DOI: 10.1097/01.inf.0000245105.99934.5f.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.